Peters, K., Reardon, D., Randazzo, D., Dutton, S., Edwards, A., Lipp, E., . . . Friedman, H. (2014). AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. Oxford University Press.
استشهاد بنمط شيكاغوPeters, Katherine, et al. AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. Oxford University Press, 2014.
MLA استشهادPeters, Katherine, et al. AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. Oxford University Press, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.